SAB Biotherapeutics, Inc.
SABS
$3.67
$0.030.82%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,840.64% | -55.54% | -38.10% | -31.71% | -18.55% |
| Total Receivables | -- | -- | -61.09% | -43.30% | -56.87% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -48.92% | 4.95% | 15.06% | 45.96% | 0.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1,116.97% | -42.88% | -31.50% | -26.88% | -17.80% |
|
|
|||||
| Total Current Assets | 1,116.97% | -42.88% | -31.50% | -26.88% | -17.80% |
| Net Property, Plant & Equipment | -4.73% | -4.54% | 7.29% | -3.97% | -4.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -70.28% | -7.18% | -6.70% | -6.28% | -1.40% |
| Total Assets | 508.87% | -20.96% | -13.75% | -17.85% | -13.08% |
|
|
|||||
| Total Accounts Payable | 12.68% | 4.05% | 48.72% | 30.66% | 10.73% |
| Total Accrued Expenses | -3.41% | 17.11% | 10.65% | -20.45% | 36.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.61% | -10.58% | 32.69% | 54.72% | -56.70% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 0.00% |
| Total Other Current Liabilities | -- | -- | -- | -- | 0.00% |
| Total Current Liabilities | 1.09% | 10.61% | 20.98% | -9.49% | 16.74% |
|
|
|||||
| Total Current Liabilities | 1.09% | 10.61% | 20.98% | -9.49% | 16.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.70% | -4.39% | 47.93% | -3.46% | -3.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.26% | 46.32% | -78.82% | 56.49% | -0.15% |
| Total Liabilities | 1.44% | 8.38% | -8.30% | 7.88% | 7.12% |
|
|
|||||
| Common Stock & APIC | 68.47% | 0.40% | 0.39% | 0.42% | 0.68% |
| Retained Earnings | 32.58% | -7.82% | -4.19% | -10.10% | -10.10% |
| Treasury Stock & Other | 1.57% | 1.70% | 0.42% | -3.43% | 1.50% |
| Total Common Equity | 1,273.76% | -43.87% | -17.57% | -29.63% | -19.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,273.76% | -43.87% | -17.57% | -29.63% | -19.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,273.76% | -43.87% | -17.57% | -29.63% | -19.99% |
|
|
|||||